Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

August 13, 2013: Today's Highlights And Insights Report. We Are Initiating Coverage On (OTCQB: ACTC), (OTCQB: CNCT), (OTCQB: APDN)

|Includes:Dominion Resources, Inc. (D)

New York, New York August 13, 2013 has been keeping an "EYE" on the markets since 1999. Make sure you sign up now to get information on what's hot and why and what's not and why not in the small cap market. If we aren't covering it, it's not worth writing about.

This article takes a look at several active stocks in the Small Cap Markets. We will bring you a brief description of their business plan, and discuss highlights from their latest filings. In a segment called "Where did the shares come from?" we have researched where the shares in the market initially came from, and the original purchase price. The final segment shows recent trading levels including volume and price. This objective information is pulled directly from the Companies featured as we feel that this information often provides insight into trading patterns. While all of these stocks are making someone money, we wish to arm our readers with the information necessary to keep you from being the one holding the stock when the music stops.

****We are highlighting the filings of the following companies***

(OTCQB: ACTC) Advanced Cell Technology Inc.

Business Plan: Advanced Cell is a life science company, focused on the emerging field of regenerative medicine. The Company's core business strategy is to develop and ultimately commercialize stem cell derived cell therapies and biologics that will deliver safe and efficacious patient therapies.

Highlights from their latest filings: "The Company has no therapeutic products currently available for sale and does not expect to have any therapeutic products commercially available for sale for a period of years, if at all."

Where did the shares come from: Of the $3,850,000 borrowed, the Company converted $3,562,215 into 76,465,706 shares of common stock during 2010. For providing investor relations services the Company issued a consultant 24,900,000 shares of its common stock on February 9, 2009. From January 15, 2013 to March 31, 2013, Lincoln Park purchased 71,547,000 shares of common stock for cash proceeds of $5,253,221. On January 23, 2013, the Company issued an aggregate of 80,357,143 free-trading shares to the CAMOFI Parties as required by the Settlement Agreement.

Litigation: In May 2012, the Company was named as a defendant in a civil action brought by the United States Securities and Exchange Commission related to transactions involving the sale and issuance of the Company's securities.

Recent Trading Levels: ACTC hit a high of $.09 with over 36 million shares traded on May 30th and we have seen a steady decline all summer, Yesterday it closed at $0.066 with over 18 million shares traded.

(OTCQB: CNCT) China Teletech Holding, Inc.

Business Plan: China Teletech, through its subsidiaries, is principally engaged in the distribution and trading of rechargeable phone cards, cellular phones and accessories within cities in PRC.

Highlights from their latest filings: "As of March 31, 2013, the Company has an accumulated deficit of $5,002,304 due to the fact that the Company continued to incur losses over the past several years."

Where did the shares come from: During the three-month period ended March 31, 2013, the CNCT issued approximately 1,000,000 and 28,000,000 shares of common stock for stock compensation and for receivable in cash to provide additional working capital to the Company respectively. During the three-month period ended March 31, 2012, the Company issued approximately 40,000,000 shares of common stock for the acquisition of CTL.

Recent Trading Levels: CNCT was at a high of $0.05 on May 14th with over a hundred thousand shares traded, it plummeted to $0.012 on May 16th with over seven million shares traded. It stayed around a penny all summer long with most day's volume being less than one hundred thousand shares traded. Then suddenly yesterday it spiked up to $0.024 with over twenty four million shares traded representing more volume then we saw in all of June and July combined.

(OTCQB: APDN) Applied DNA Sciences, Inc.

Business Plan: Applied DNA is a provider of modified and derivatized botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, and protect governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA, SmartDNA®, DNANet®, BioMaterial Genotyping™, digitalDNA®, and Cashield®, are their principal anti-counterfeiting and product authentication solutions.

Highlights from their latest filings: "Net loss for the nine months ended June 30, 2013 increased to $13,968,001 from a net loss of $5,383,432 for the nine months ended June 30, 2012."

Where did the shares come from: As of June 30, 2013, 121,354,192 APDN employee stock options were outstanding with 91,892,325 shares vested and exercisable. On November 28, 2012, APDN entered into a purchase agreement with Crede and issued Series A, B and C Warrants allowing Crede to purchase 10,752,688, 29,569,892 and 26,881,720 shares of Common Stock, respectively.

Litigation: Demodulation, Inc. v. Applied DNA Sciences, Inc., et al. (Civil Action No. - 2:11-cv-00296-WJM-MF, District of New Jersey) and Smartwater, Ltd. v. Applied DNA Sciences, Inc. (No. 12-CV-05731-JS-AKT (E.D.N.Y.)) are both pending patent infringement cases.

Recent Trading Levels: APDN traded over $0.26 on volume of over 20 million shares on May 15th. Since then we have seen a steady decline in both price and volume over the course of the summer. It closed Yesterday at $0.138 with over 5.7 million shares traded.

Disclosure: has been actively profiling small companies since 1999 bringing our readers timely and valuable market information first. Nothing in our reports or on our site should constitute a recommendation to buy or sell any stock. Investors should conduct their own due diligence and consult with a stock broker or investment advisor before making any investment decision. Some of our statements are our opinion and should be taken as such, and there are forward looking statements. Read our full disclosure at



Stocks: D